The prolonged effect observed in the IVTA group may indicate its broader anti-inflammatory action in contrast to the VEGF-specific inhibition provided by IVB, which carries significant implications for managing retinal diseases. The gene discussed is VEGFA; the disease is Abnormal retinal morphology.